NCT03200379 Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
| NCT ID | NCT03200379 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital |
| Condition | Hepatitis C, Chronic |
| Study Type | OBSERVATIONAL |
| Enrollment | 150,000 participants |
| Start Date | 2017-06-15 |
| Primary Completion | 2037-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150,000 participants in total. It began in 2017-06-15 with a primary completion date of 2037-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan
Eligibility Criteria
Inclusion Criteria: 1\. Patients who are treated with DAA and have willingness to participate in this registry. Exclusion Criteria: Chronic hepatitis C patients who are unwilling to participate in the study and do not provide written informed consent for participation.
Contact & Investigator
Ming-Lung Yu, MD., PhD
PRINCIPAL INVESTIGATOR
HepatobiliaryDivision, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Frequently Asked Questions
Who can join the NCT03200379 clinical trial?
This trial is open to participants of all sexes, studying Hepatitis C, Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03200379 currently recruiting?
Yes, NCT03200379 is actively recruiting participants. Contact the research team at fish6069@gmail.com for enrollment information.
Where is the NCT03200379 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan.
Who is sponsoring the NCT03200379 clinical trial?
NCT03200379 is sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. The principal investigator is Ming-Lung Yu, MD., PhD at HepatobiliaryDivision, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. The trial plans to enroll 150,000 participants.